September 20, 2025 8:30AM to 3:45PM

12th ANNUAL MYASTHENIA GRAVIS

PATIENT EDUCATION DAY

Learn from and ask questions to our expert panel of speakers.

Discover new treatments and research in MG.

Connect and share knowledge with other MG patients.

Our annual Myasthenia Gravis (MG) Patient Education Day is a unique opportunity for MG patients to come together as a community and learn more about the assessment, treatment, and management of MG from experts in the field. Information sessions will include presentations around new developments in MG, as well as discussions around quality of life, and coping with MG.

For inquiries, concerns or suggestions about the event, please email mgdayab@gmail.com.

**Registration and attendance will be free of charge this year, but limited to 200 attendees on a first come first serve basis.**

Donations to the University Hospital Foundation - The Wismer Fund are welcome.

Donate to the UHF

MEET THE SPEAKERS

Dr. Hans Katzberg

Professor of Medicine, Krembil Family Chair Neurology, Division Head UHN/Sinai Health, Clinical Investigator, Krembil Brain Institute

University of Toronto

Dr. Cecile Phan

Associate Clinical Professor of Medicine, Director of Neuromuscular and Postgraduate Fellowship Programs, Department of Medicine

University of Alberta

Dr. Zaeem Siddiqi

Professor of Medicine, Director of Neuromuscular & Autonomic Diseases Programs, Department of Medicine,

University of Alberta

Rhonda-Mae Nelson

Master Practitioner Clinical Counsellor

Psychotherapist

Registered Qualified Supervisor

Bridgewater Healing Inc.

Diagnosed with MG in 2000, Warren Wismer has worked tirelessly to promote awareness of this condition. To this purpose, Warren and Victoria Wismer established the Wismer Fund in Support of MG through the University Hospital Foundation.

The Wismer Fund helps foster an understanding and awareness of MG for both healthcare professionals and patients through conferences, learning opportunities and other activities. The fund supports continued improvements in treatments and helps empower people knowledgeably participate in their treatment decisions and to live more comfortably with MG.